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Abstract
Background: Abnormal handling of E. coli by lamina propria (LP) macrophages may contribute to Crohn’s disease
(CD) pathogenesis. We aimed to determine LP macrophage phenotypes in CD, ulcerative colitis (UC) and healthy
controls (HC), and in CD, to compare macrophage phenotypes according to E. coli carriage.
Methods: Mucosal biopsies were taken from 35 patients with CD, 9 with UC and 18 HCs. Laser capture microdissection
was used to isolate E. coli-laden and unladen LP macrophages from ileal or colonic biopsies. From these macrophages,
mRNA was extracted and cytokine and activation marker expression measured using RT-qPCR.
Results: E. coli-laden LP macrophages were identified commonly in mucosal biopsies from CD patients (25/35, 71 %),
rarely in UC (1/9, 11 %) and not at all in healthy controls (0/18). LP macrophage cytokine mRNA expression was greater
in CD and UC than healthy controls. In CD, E. coli-laden macrophages expressed high IL-10 & CD163 and lower TNFα,
IL-23 & iNOS irrespective of macroscopic inflammation. In inflamed tissue, E. coli-unladen macrophages expressed
high TNFα, IL-23 & iNOS and lower IL-10 & CD163. In uninflamed tissue, unladen macrophages had low cytokine
mRNA expression, closer to that of healthy controls.
Conclusion: In CD, intra-macrophage E. coli are commonly found and LP macrophages express characteristic
cytokine mRNA profiles according to E. coli carriage. Persistence of E. coli within LP macrophages may provide a
stimulus for chronic inflammation.
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Background
The exact pathogenesis of Crohn’s disease (CD) remains
unclear, but it is likely to result from a dysfunctional
interaction between components of the intestinal micro-
biota and an abnormal innate immune system and mu-
cosal barrier [1, 2].
Potential roles for numerous bacteria in CD pathogenesis
have been investigated [3–5], but none have been shown to
be clearly causative. A possible role for E. coli has been
highlighted by the isolation of a pathogenic subset labelled
adherent-invasive E. coli (AIEC) from the mucosa in some
patients with CD [6, 7]. Studies show that AIEC survive
and replicate within macrophages in vitro [8, 9] and that E.
coli can be isolated from lamina propria (LP) macrophages
in CD [5, 10, 11]. This has led to the hypothesis that E. coli
may cross the mucosal barrier and persist within LP mac-
rophages as a stimulus for chronic inflammation in CD. Of
note, most studies report that AIEC are isolated in less
than half of CD cases [6, 7] and other less pathogenic
E. coli can also be recovered by intracellular culture in
CD [6, 12]. In addition, recent data demonstrates that
macrophages may be dysfunctional in CD [1], and so it
is likely that both bacterial and host factors contribute
to intra-macrophage bacterial persistence in CD.
Human macrophage phenotypes are heterogeneous and
plastic [13, 14]. One broad classification distinguishes M1
inflammatory macrophages, which express high IL-12,
iNOS and low IL-10, from M2 regulatory macrophages
* Correspondence: elliott_timothy@hotmail.com
†Equal contributors
1Diabetes and Nutritional Sciences Division, King’s College London, Franklin
Wilkins Building, 150 Stamford Street, London SE1 9NH, UK
2Department of Gastroenterology, Guy’s and St Thomas’ NHS Foundation
Trust, St Thomas’ Hospital, London SE1 7EH, UK
Full list of author information is available at the end of the article
© 2015 Elliott et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium,
provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Elliott et al. BMC Gastroenterology  (2015) 15:75 
DOI 10.1186/s12876-015-0305-3
which express high IL-10 and low IL-12 [14]. In diseases
such as atherosclerosis and malignancy, these polarised
macrophage phenotypes make particular contributions to
pathogenesis [14]. Resident lamina propria macrophages
in health are characterised by inflammatory anergy but en-
hanced phagocytic and microbicidal capacity [15]. In CD,
lamina propria macrophages are more numerous, prob-
ably due to recruitment of CD14+ monocytes, and have
greater pro-inflammatory cytokine expression [16]. How-
ever, the roles of differing macrophage phenotypes in CD
pathogenesis are incompletely understood.
The aim of this study was to characterize macrophage
phenotypes according to E. coli carriage in mucosal bi-
opsies from patients with CD, UC and healthy controls.
This may provide insight into potential roles for macro-
phage phenotypes and E. coli in CD pathogenesis.
Methods
Study participants
Patients with IBD were recruited at routine colonoscopy.
Diagnoses of CD and UC were established by conventional
criteria. Asymptomatic healthy controls were recruited at
surveillance colonoscopy for previous colorectal polyps or
a family history of colorectal cancer. Clinical and demo-
graphic data were collected. All participants provided
written consent and the study received ethical approval
(REC ref. 07/H0804/78).
Mucosal biopsies and biopsy processing
Biopsies were taken from the colon in healthy controls
and from inflamed +/- uninflamed sites (ileal (CD only)
or colonic mucosa (CD and UC)) in patients with IBD.
In a subgroup of CD patients, paired inflamed and unin-
flamed biopsies were taken from the same segment of
bowel. Endoscopic severity was graded using the simple
endoscopic score for CD (SES-CD) [17] and the modi-
fied Baron’s score for UC [18]. Histological severity was
graded from a biopsy adjacent to the study biopsy. Biopsies
were snap frozen in liquid nitrogen and stored at -80 °C.
Samples were removed from storage and orientated onto
OCT media. 6 μm frozen sections were cut onto 1 mm
PALM membrane slides.
Immunodetection of CD68+ macrophages and presence
or absence of intracellular E. coli
LP macrophages with or without E. coli co-localisation
were identified in mucosal biopsies using previously
validated immunolabelled CD68+ [19] and E. coli anti-
bodies [20]. A rapid indirect immunostaining protocol
was employed for macrophage-specific CD68 (PG M1)
to minimize risk of mRNA degradation [21]. CD68 positive
cells were detected using a Vectastain ABC-AP kit and a
Vector Red chromogenic substrate. Detection of intracellu-
lar E. coli was achieved by co-staining CD68+ macrophages
with an anti-E. coli polyclonal antibody and labeled with
Vector Blue chromogenic substrate. Staining was visualized
using a Zeiss axioplan MOT 400 M microscope. CD68+
cells co-localising with anti-E. coli antibody were termed
E. coli-laden macrophages (Fig. 1a, b). CD68+ cells without
anti-E. coli antibody co-localisation were termed
E. coli-unladen macrophages (Fig. 1c).
Laser capture microdissection (LCM) of macrophages and
mRNA extraction
Laser capture was performed using a PALM microsystem.
CD68+ only or CD68+/E. coli + cells were isolated under
direct microscopic visualisation (Fig. 1d, e) and catapulted
onto a PALM adhesive cap. 400-500 E. coli-unladen and,
when present, 400-500 E. coli-laden, macrophages were
collected per biopsy for sufficient pooled RNA extraction
(approximately 35 ng). RNA extraction was performed
using the Cells Direct kit (Invitrogen). Cells were incubated
with lysis solution at 75 °C for 15 mins. Contents were spun
down and treated with DNAse1 for 5 mins. The reaction
was stopped by adding 25 mM EDTA and kept on ice. RNA
was quantified using a Nanodrop spectrophotometer
(Thermofisher) and RNA integrity was assessed using an
Agilent 2100 Bioanalyser. The range of RIN values was 8.7 –
9.5 with a cut off of 8.0 for sufficient integrity of RNA [22].
Primer design
RT-qPCR assays were designed, validated and optimized
according to the Minimum Information for Publication
of Quantitative Real-Time PCR Experiments (MIQE) guide-
lines [23]. The mRNA sequences for macrophage activation
markers (CD163, iNOS and COX-2) and cytokines
(IL-6, IL-8, IL-10, IL-23 and TNFα) (primer details - Table 1)
were identified using the Genbank database. Primers
were designed using Beacon Designer, version 7.2,
selecting for a primer annealing temperature of 55 °C and
amplicon length of <100 bp. Primer and amplicon
specificity were checked using Primer-BLAST (http://
www.ncbi.nlm.nih.gov/tools/primer-blast/) and nucleotide-
BLAST (www.ncbi.nlm.nih.gov/BLAST/) respectively. Tar-
get secondary structures and primer/template accessibility
were assessed using the MFOLD web server (http://
www.bioinfo.rpi.edu/applications/mfold) using corrections
for ionic conditions of 50 nM Na++ and 3 mM Mg++ and
a folding temperature of 55 °C. Lyophilised primers were
reconstituted in 1xTE buffer to make a stock solution of
100 μM/μl.
RT-qPCR assays
RT-qPCR assays were performed using target-specific pri-
mer sequences on a Rotor-Gene 6000, with quantification
cycles (Cqs) calculated using Corbett software version 1.7
(build 65). Experiments were carried out in duplicate, and
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data obtained from replicates yielding a standard deviation
of Cq values of <0.5 were used for further analysis.
Quantification and normalisation of data
mRNA copy numbers were determined from target-
specific standard curves of known concentration (10-fold
serial dilutions of RNA extracted from fresh frozen tissue
biopsy; 100 ng/μl – 1 pg/μl) included with every RT-qPCR
run. Cq values were plotted against the logarithm of calcu-
lated copy numbers and individual target copy numbers
were obtained from the linear regression of the standard
curve. Data for each target were normalized against fresh
biopsy total RNA and expressed as copies of mRNA/μg
total RNA, as recommended [24]. mRNA expression of
candidate genes in inflamed CD biopsies was analysed
relative to non-inflamed biopsies and controls.
Statistical analysis
Statistical analysis was performed using SPSS 19.0. Un-
paired t-tests and one-way analysis of variance (ANOVA)
were used to compare means between 2 groups or greater
than 2 groups respectively. Paired t-tests were used for
within subject comparisons. Where normality could not
be confirmed, non-parametric testing was performed.
Fisher’s exact test was used to analyse contingency ta-
bles. ANCOVA (ANOVA with covariates) was used to
Fig. 1 CD68 staining macrophages (red) can be seen to contain E. coli ( blue ) in the biopsy from a patient with CD ((a) low power (x40), (b) high
power (x63), but not in biopsies from a healthy control (x20) (c). Labelled lamina propria macrophages (d) before and (e) after laser
capture microdissection
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determine the effect of age on expression of cytokines and
markers. P values < .05 were considered significant.
Results
Patients and controls
Data was analysed from 35 patients with CD, 9 with UC
and 18 healthy controls. Mean age was greater in healthy
controls (49 years) than in patients with CD (37 years)
(P = .005) but not significantly greater than in patients with
UC (39 years) (P = .149). Other clinical and demographic
details are recorded in Table 2. Biopsy site, and endoscopic
and histological severity are recorded in Table 3.
Prevalence of E. coli-laden LP macrophages in CD, UC and
healthy controls
E. coli-laden macrophages were commonly identified in
mucosal biopsies from CD patients (25/35 (71 %)), rarely
in UC (1/9 (11 %)) and were not present in any of 18
healthy controls (Table 3). The presence of E. coli-laden
macrophages in CD correlated with endoscopic severity
(P < .001) (Fig. 2) but not with other clinical or demo-
graphic factors (age, gender, smoking status, disease loca-
tion, immunomodulation or site of biopsy - data not
shown). Six of the 35 CD patients had paired biopsies taken
from macroscopically inflamed and uninflamed mucosa. In
these 6 patients, E. coli-laden LP macrophages were present
in 6/6 inflamed and 3/6 uninflamed biopsies respectively.
Macrophage cytokine and surface marker mRNA
expression in CD, UC and healthy controls
LP macrophage cytokine mRNA expression in healthy
controls is low
Mean mRNA expression of most cytokines and surface
markers (TNFα, IL-23, IL-6, IL-8 & IL-10, iNOS &
COX2 (P < .001 for each)) was lower in LP macrophages
from healthy controls than from E. coli-laden or unladen
macrophages from inflamed CD mucosa (Fig. 3(a) to (g)).
Mean CD163 mRNA expression in LP macrophages
from healthy controls was not significantly different to
E. coli-unladen macrophages (P = .173) but lower than
E. coli-laden CD macrophages (P < .001) (Fig. 3(h)).
In inflamed CD mucosa, E. coli-unladen macrophages have
high proinflammatory cytokine mRNA expression, whereas
E. coli-laden macrophages have high IL-10 and CD163
mRNA expression
In inflamed mucosal biopsies from the 25 CD patients in
whom both E. coli-laden and unladen macrophages were
present, E. coli-unladen macrophages had higher mean
pro-inflammatory cytokines (TNFα, IL-23, IL-6, IL-8)
and iNOS expression (Fig. 3(a) – (e), for each; P < .001)
than E. coli-laden macrophages (Fig. 3). E. coli-unladen
macrophages also expressed higher COX-2 than E.
coli-laden macrophages (Fig. 3(f ) P < .001). Conversely,
Table 1 Oligonucleotide primer pairs used for RT-qPCR analysis
Oligo name GC % Sequence
TNFα Sense 50 CGAACATCCAACCTTCCAAAC
TNFα Anti-Sense 42 TGGTGGTCTTGTTGCTTAAAGTTC
iNOS Sense 42 CATCAACAACAATGTGGAGAAAGC
iNOS Anti-sense 55 TCTGCTGCTTGCTGAGGTTG
IL-6 Sense 48 GACAGCCACTCACCTCTTCAG
IL-6 Anti-sense 50 GGAAGGTTCAGGTTGTTTTCTGC
IL-8 Sense 52 CAGCCACTACAAACAGAGCACTG
IL-8 Anti-sense 48 CAAAGGGATGACAAGCAGAAAG
IL-23 Sense 54 GGA CAA CAG TCA GTT CTG CTT GC
IL-23 Antisense 50 GGA GGC TGC GAA GGA TTT TG
IL-10 Sense 55 CCAAGACAACACTACTAAGGCTCCTTT
IL-10 Antisense 48 GCTTCTTATATGCTAGTCAGGTA
COX-2 Sense 59 CTCCTATTATACTAGAGCCCTTCCTC
COX-2 Anti-sense 58 TTTTCCAATCTCATTTGAATCAGG
CD163 Sense 48 AGGGTGATAGAAGAGGCCAACACT
CD163 Anti-sense 50 TTGCACCGGACAAACTTCATGGC
Genbank accession numbers: iNos (L09210), Cox-2 (NM000963), IL-6 (M14584),
TNF (M10988), IL-8 (Y00787), IL-10 (M57627), IL-23 (M652720), CD163 (NM0004244)
Table 2 Clinical and demographic details of study participants
CD UC Healthy controls
Number of participants 35 9 18
Age in years mean (range) 37 (19-65) 39 (27-68) 49 (23-62)
Gender (f, m) 17, 18 3, 6 8, 10
Smoking status
Never 13 5 10
Current 7 1 3
Ex- 3 2 2
unknown 12 1 3
Disease distribution
Ileal only 6 - n/a
Ileo-colonic 9 - n/a
Colonic only 20 9 n/a
Immunomodulation
Yes 13 4 0
No 22 5 18
Anti-TNFα therapy
Yes 2 0 0
No 33 9 18
CD Crohn’s disease; UC ulcerative colitis; f female; m male; ex-, ex-smoker;
TNFα, tumour necrosis factor-alpha; n/a, not applicable
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E. coli-laden macrophages had higher IL-10 and CD163
expression (Fig. 3(g), (h), for each; P < .001) than E. coli-
unladen macrophages. Macrophage mRNA profiles in CD
were not associated with any pattern of disease distribu-
tion, biopsy site (ileal or colonic), current IM, anti-TNFα
therapy or smoking status (data not shown).
E. coli-unladen macrophages are more pro-inflammatory
when E. coli-laden macrophages are present
Mean pro-inflammatory cytokine mRNA expression of
E. coli-unladen macrophages was higher in the 25 CD
patients in whom E. coli-laden macrophages were also
present compared with that in E. coli-unladen macro-
phages in the 10 CD patients’ biopsies in which E. coli-
laden macrophages were not present (TNFα, IL-23, IL-6,
IL-8, iNOS; all P < .001) (Fig. 3(a) – (e)).
In UC, E. coli-unladen LP macrophages express elevated
cytokine mRNA and E. coli-laden macrophages are rare
Only 1/9 biopsies from patients with UC contained E.
coli-laden LP macrophages. Mean TNFα expression of E.
coli-unladen macrophages in UC was not significantly
different to that in E. coli-unladen macrophages in CD
(Fig. 3(a)). Other mean cytokine and surface marker ex-
pression in UC E. coli-unladen macrophages varied from
CD as follows: IL-6 & IL-8 not significantly different to
CD E. coli-laden macrophages; iNOS & CD163, intermedi-
ate between CD E. coli-laden and unladen; and COX2 not
significantly different to healthy controls (IL-23 and IL-10
not measured for UC) (Fig. 3).
Macrophage phenotypes in paired inflamed and uninflamed
biopsies in CD
E. coli-laden macrophages expressed a similar phenotype
in inflamed and uninflamed mucosa (Fig. 4(a) – (d)).
Conversely, E. coli-unladen macrophages from uninflamed
mucosa expressed much lower cytokine and surface marker
mRNA levels than in inflamed mucosa (for all P < .001
except CD163 P = NS) (Fig. 4(a) – (d)). These were at
levels closer to, and in some cases, indistinguishable from
controls.
Discussion
In this study, E. coli-laden lamina propria macrophages
were identified commonly in CD, rarely in UC and not
at all in healthy control mucosal biopsies. In CD, there
were distinct macrophage phenotypes in relation to the
carriage of E. coli.
Intra-macrophage E. coli in CD
We found that E. coli can be identified within LP macro-
phages in most CD patients using immunohistochemistry
with an anti-E. coli specific polyclonal antibody. This con-
curs with previous studies that demonstrate E. coli within
LP macrophages in CD using immunohistochemistry [5]
and FISH [25] or within granulomas using LCM and
nested PCR [10]. In future studies, further confirmation of
the presence of E. coli within lamina propria macrophages
in CD could be achieved using an alternative technique
such as 16S rRNA PCR. Additionally, the presence of
other bacteria within macrophages could be determined
Table 3 Biopsy site and proportion of subjects with E. coli-laden
macrophages
Subject group CD UC Healthy
controls
Subject numbers 35 9 18
Biopsy site
rectum 11 9 18
colon (other) 9 - -
ileum 14 - -
jejunum 1 - -
Total 25/35 (71 %)
(71 %)((71 %)
1/9 (11 %) 0/18 (0 %)
According to histological severity
normal 3/7 0/0 0/18
mild 20/26 0/8 -
moderate 2/2 1/1 -
severe 0 0/0 -
According to endoscopic severity score
CD patients
SES-CD (biopsied segment)
0 0/3
1-2 -
3 6/11
4 13/15
5-7 6/6
>7 -
SES-CD (total score)
0 0/3
1-2 -
3-4 8/14
5-8 9/10
9-13 7/7
>13 -
UC patients
Modified Baron score
0 -
1 0/8
2 1/1
3 -
patient with jejunal CD - SES-CD total not recorded as no colonoscopy
HC healthy controls; UC ulcerative colitis; CD Crohn’s disease
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by extracting DNA from laser-captured macrophages,
performing bacterial 16S rDNA sequencing and com-
paring any 16S rDNA sequences present to database
reference bacterial sequences [26].
It is possible that the presence of intramacrophage E.
coli in CD results from successful adherence to and in-
vasion of the mucosa by AIEC, with subsequent survival
and replication within LP macrophages. Certainly, in vitro,
AIEC have been shown to possess properties that might
facilitate this process [8, 9]. However, it is also possible
that an innate defect of bacterial killing by LP macro-
phages contributes to E. coli persistence within macro-
phages, a concept which is also supported by the presence
of macrophage cytokine defects and mutations in bacterial
handling genes in CD [1, 27, 28]. We did not determine
whether intra-macrophage E. coli were AIEC in our study
because these E. coli cannot be distinguished morpho-
logically. However, using culture of biopsies with gentami-
cin protection to isolate intracellular E. coli from the
mucosa in CD, we have found that only a minority of
intracellular isolates have adherent and invasive properties
in vitro [12].
The lower prevalence (1/9) of E. coli-laden macro-
phages in UC is in keeping with previous reports of
lower intramucosal bacteria in UC than CD [6, 29].
Meanwhile, the absence of E. coli-laden macrophages in
all 18 healthy subjects illustrates that the mucosal immune
system prevents bacterial persistence within the LP in
health.
Measurement of macrophage surface marker & cytokine
mRNA expression using real time RT-PCR
Real-time RT-PCR can provide a sensitive and accurate
measurement of mRNA when performed in accordance
with the MIQE guidelines. Normalisation of mRNA data
remains a contentious issue. House-keeping genes such
as GAPDH and β-Actin have been proposed as being
stable appropriate reference genes for normalisation. Prior
to initiation of this study, we performed preliminary
experiments using GAPDH and β-Actin and found that
these reference genes were unstable in these inflamed
tissue samples. We also have previously published data
demonstrating that internal reference genes may not be
appropriate for normalisation of qPCR data for mRNA,
especially when derived from tissue biopsies [30, 31].
However, the use of total RNA for normalisation has
been demonstrated to be valid [24] and produce quanti-
fication results that are biologically relevant [30] as long
as certain criteria are met [32, 33]. These are that the RIN
is above 8 (which can be considered perfect total RNA for
downstream applications [22]) which was confirmed using
the Agilent 2100 Bioanalyzer in our study, and the use of
small amplicons which minimise the variability caused by
RNA degradation. Hence, our decision to use total RNA
for normalisation in this study is valid, especially as we
are reporting very large and characteristic differences in
expression of mRNA for a range of cytokines between
Crohn’s disease, healthy controls and UC that are not
consistent with chance RNA degradation.
Characteristic LP macrophages according to E. coli carriage
in CD
In healthy controls, cytokine and surface marker mRNA
expression in macrophages from uninflamed colonic mu-
cosa were low, in keeping with previous data on intestinal
macrophages in health [34]. In inflamed CD mucosa, there
was clear differentiation of macrophage cytokine and
surface marker profiles according to E. coli carriage (E.
coli-unladen; higher proinflammatory cytokines (TNFα,
IL-23, IL-6, IL-8) and iNOS, and E. coli-laden; higher
IL-10 and CD163, both characteristic features of regula-
tory macrophages). The phenotype of E. coli-unladen
macrophages in CD is consistent with that of recently
recruited CD14+ macrophages, which secrete high TNFα
and IL-23 and are more numerous in active CD [16]. It is
likely that these activated macrophages contribute sig-
nificantly to inflammation and recruitment of other pro-
inflammatory cells important in CD pathogenesis such
as Th17 cells [16]. E. coli-unladen macrophages in
uninflamed mucosa from CD patients with active
disease expressed very low cytokine mRNA levels, simi-
lar to healthy controls, and are therefore likely to be
inactive resident LP macrophages [15].
The observed phenotype (high IL-10, lower TNFα) of
E. coli-laden macrophages in CD might represent an
appropriate regulatory response to microbial encroach-
ment, or may facilitate E. coli persistence, and thus contrib-
ute to pathogenesis. Supporting the former supposition,
the immunoregulatory role of macrophages secreting IL-10
Fig. 2 Higher median endoscopic severity score for CD patients
with E. coli-laden LP macrophages compared with those without
E. coli-laden LP macrophages at biopsy (P < .001, Mann-Whitney
test). SES-CD; simplified endoscopic score for Crohn’s disease,
Mø; macrophages
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Fig. 3 (See legend on next page.)
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is well documented [35]. However, IL-10 also facilitates
intracellular persistence of numerous microorganisms [35],
possibly due to inhibition of autophagy [36]. Interestingly,
in Whipple’s disease, Tropheryma Whipplei accumulate in
duodenal macrophages which express a similar phenotype
to the E. coli-laden macrophages in this study (high IL-10,
CD163) which is thought to facilitate their persistence [37].
E. coli-laden macrophages were present and also
expressed a high IL-10 phenotype in uninflamed mucosa
in 3 of the 6 CD patients with active disease in whom
paired inflamed/uninflamed biopsies were taken. This
raises the possibility that E. coli access the mucosa at an
early stage of CD pathogenesis rather than as a conse-
quence of a disrupted inflamed mucosa. Of note, the
presence of E. coli-laden macrophages correlated with
endoscopic severity and higher pro-inflammatory cyto-
kine mRNA expression of E. coli-unladen macrophages.
This highlights further the dilemma of cause and effect as
this may either be because the presence of E. coli in LP
macrophages causes intestinal inflammation or that their
presence is merely a consequence of inflammation.
In UC, E. coli-unladen macrophage cytokine and surface
marker expression were elevated often to similar levels as
in CD, however COX-2 mRNA was substantially lower in
Fig. 4 E. coli-laden macrophages express a similar phenotype in inflamed and uninflamed tissue high IL-10 (c), CD163 (d), lower TNFα (a)
and IL-23 (b). E. coli-unladen macrophages express a proinflammatory phenotype in inflamed tissue high TNFα (a), and IL-23 (b), lower IL-10 (c),
CD163 (d) but in uninflamed tissue express cytokine mRNA expression nearer to that of healthy controls (dotted line = healthy control median mRNA
expression). MØ =macrophage. *P < .05, **P < .01, ***P < .001. Paired t tests used for within subjects statistical analysis. Presence or absence of
inflammation determined by macroscopic appearance at endoscopy
(See figure on previous page.)
Fig. 3 Cytokine and surface marker mRNA levels in healthy controls, CD patients with E. coli laden macrophages, CD patients without E. coli laden
macrophages and UC patients. Fig. 3(a) From left to right: Healthy controls (n = 18); LP macrophages have low TNFα mRNA expression. Inflamed
mucosal biopsies from CD patients with both E. coli-laden and unladen macrophages present (n= 25); E. coli-unladen macrophages had higher mean
TNFα mRNA expression (P< .001) than E. coli-laden macrophages. CD patients without E. coli-laden macrophages (n= 10); TNFαmRNA expression of E.
coli-unladen macrophages were lower than in E. coli-unladen macrophages from the 25 CD patients in whom both E. coli-laden and unladen were present
(P< .001). UC patients (n = 9); E. coli-unladen LP macrophages showed elevated TNFα mRNA levels. Fig 3(b) to (f): Expression of other proinflammatory
cytokines (IL-23, IL-6, IL-8) and iNOS is similar to the pattern of TNFα expression in samples from each subject group. Fig. 3 (g) Expression of COX2 is similar
to the pattern of TNFα in each group but is lower in UC than in CD. In distinction to the pattern of TNFα expression, Fg. 3 (g) and 3(h) demonstrate that
IL-10 and CD-163 mRNA expression are higher in E. coli-laden than E. coli-unladen macrophages in CD (for each; P< .001). *P< .05, **P< .01, ***P< .001.
Comparisons of means made with one-way ANOVA and Games-Howell post-hoc pair-wise comparisons. There was no UC data for IL-23 or IL-10. Only one
UC patient had E. coli-laden macrophages (cytokine data not shown)
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UC. This may be in keeping with a recent Danish study
that reported the association of a COX-2 gene polymorph-
ism (A-1195G variant allele) with UC but not CD [38].
The authors hypothesised that the mutation, which is
associated with low COX-2 activity, may lead to increased
UC susceptibility because of reduced prostaglandin syn-
thesis as prostaglandins regulate mucosal inflammation. It
would be of interest to correlate the prevalence of this
mutation with macrophage COX-2 expression in UC in
future work.
Conclusions
This study provides novel insights into the presence of
intramacrophage E. coli and lamina propria macrophage
phenotypes in relation to the presence or absence of
intracellular E. coli in Crohn’s disease. Further work is
required to determine the pathogenic significance of these
macrophage subtypes in CD. Clarification of whether
E. coli-laden macrophages are attempting to ameliorate
inflammation or whether they contribute to microbial
persistence and disease pathogenesis will also be im-
portant. This may lead to therapies aimed at manipula-
tion of macrophage phenotypes [13, 14] and renewed
interest in the use of antibiotics that target intracellu-
lar E. coli for the treatment of CD [39].
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